Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03169023 · ClinicalTrials.gov registry record · NA
Scale Down for Endometrial Cancer
A NA study of Endometrial Cancer and Cancer of the Endometrium, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 155
- Enrollment target
- 1
- Study location
NCT03169023: Completed NA study of Endometrial Cancer and Cancer of the Endometrium, sponsored by Washington University School of Medicine.
NCT03169023 is a NA study of Endometrial Cancer and Cancer of the Endometrium that has completed, run by Washington University School of Medicine. The registered enrollment target is 155 participants, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03169023, a NA study of Endometrial Cancer and Cancer of the Endometrium, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 155 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposal will pilot a weight management program for patients with endometrial cancer, the cancer most associated with obesity. If successful, this pilot could be expanded to include obese women with other gynecologic cancers (ovarian and cervical) and could be expanded and adapted for use not only upon completion of treatment, but during chemotherapy or radiation. Furthermore, other obstetricians and gynecologists could use this strategy for obese women as a practical cancer prevention strategy for obesity-associated cancers.
Primary Outcome
-The purpose will be to obtain estimates for the size of an effect achievable by the experimental intervention in order to power and justify a full-scale trial of a weight management program in women with endometrial cancer.
Conditions Studied
Interventions
- BEHAVIORAL ScaleDown
- BEHAVIORAL Enhanced Usual Care Packets
- OTHER 12-Item Short Form Health Survey
- OTHER International Physical Activity Questionnaire short form
- OTHER Multidimensional Body Self Relations Questionnaire - Appearance Subscales
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2017-02-21 |
| Est. Completion | 2019-02-03 |
| Phase | NA |
What the finished NCT03169023 record still lists
NCT03169023 is an interventional study that assigns participants to a tested intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (70% lower).
The record links to 2 conditions, with Endometrial Cancer appearing as the primary indexed condition, and to 5 interventions - of which ScaleDown is the first listed.
NCT03169023 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03169023 about?
NCT03169023 is a clinical study titled "Scale Down for Endometrial Cancer". This proposal will pilot a weight management program for patients with endometrial cancer, the cancer most associated with obesity. If successful, this pilot could be expanded to include obese women with other gynecologic cancers (ovarian and cervical) and could be expanded and adapted for use not o...
What is the current status of trial NCT03169023?
This trial is currently completed. It is a NA study. The enrollment target is 155 participants. The study started on 2017-02-21. Estimated completion is 2019-02-03.
What conditions does trial NCT03169023 study?
This clinical trial studies the following conditions: Endometrial Cancer, Cancer of the Endometrium.
What interventions are being tested in trial NCT03169023?
The interventions under investigation include: ScaleDown (BEHAVIORAL), Enhanced Usual Care Packets (BEHAVIORAL), 12-Item Short Form Health Survey (OTHER), International Physical Activity Questionnaire short form (OTHER), Multidimensional Body Self Relations Questionnaire - Appearance Subscales (OTHER).
Who is sponsoring clinical trial NCT03169023?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03169023 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03169023's enrollment target sits among peer trials
155 77th of 181 higher than 105 of 181 other Endometrial Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometrial Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
-
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer
RECRUITING · NA
-
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
RECRUITING · NA
-
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI